We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 0.82% | 61.50 | 61.00 | 62.00 | 61.50 | 61.50 | 61.50 | 13,448 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 29.49M | -302k | -0.0043 | -143.02 | 43.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/4/2015 11:09 | Ray, sorry but I don't know. No prob getting a quote. 15p to sell, 15.43p to buy. | bamboo2 | |
10/4/2015 11:00 | Bam, why is it in auction? News of some kind? | rayrac | |
08/4/2015 22:04 | Ray, NHSBT is currently expanding the use of dCell Dermis in London Hospitals to cure diabetic leg and foot ulcers. This could well lead to greater visibility within the speciality of chronic wound care and help to build evidence of the efficacy of our product. | bamboo2 | |
07/4/2015 15:15 | So it's wait for May! Thanks for the reminder anyway, closer than the average guy?😜 | rayrac | |
07/4/2015 12:45 | YORK, 9th March 2015 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix"), the regenerative medical devices company, announces that it will publish its unaudited preliminary results for the year ended 31 January 2015, on Monday 11th May 2015. | channel pirate | |
07/4/2015 09:53 | Need news! | rayrac | |
29/3/2015 15:00 | Large trade Friday after hours [16:43:44] 15,000,000 16.415p enough to generate a holdings rns? | bamboo2 | |
29/3/2015 12:39 | Agree, Bamboo. An illiquid share with a news vacuum is going to be a sitting duck for manipulation by those in a strong position to do so. | luminoso | |
26/3/2015 17:26 | Looking at the timing of the sells today I would say there is a concerted effort to knock the share price during the closed period, assuming that those in the know are indeed barred from dealing. This could turn into an excellent chance to buy-in or add. If this is the case, there is, however, plenty of time. I have previously attempted to trade this share, but is difficult with charges and the spread, to show a worthwhile profit. | bamboo2 | |
26/3/2015 08:19 | When are the finals? Ok, 11th May. I don't need help.😩 | rayrac | |
25/3/2015 16:29 | Heads down looking😳 | rayrac | |
24/3/2015 22:10 | Hopefully we will have some news on the progress of Dermapure before finals or at the very least a bit of PR. | bobsgonnamakemerich | |
24/3/2015 09:27 | DermaPure is such a cutting edge groundbreaking product, and it's gaining traction in many markets, especially in the important US market place. As a small company, small but not insignificant trades can swing the price significantly, which is a shame, but goes with the territory: big swings can cause trepidation, but for longer term holders convinced of the potential gain that DermaPure sales will in time bring about, this is definitely a buy and keep hold of share, IMHO. | andrewbaker | |
24/3/2015 07:45 | True, Ray. These insignificant trades do still move the price significantly, it seems. As long as its all noise for now, I am happy. | luminoso | |
24/3/2015 07:41 | Any buying, or selling, of that volume, means nothing of consequence. I hold 50k and that's absolute peanuts in the grand scheme of things! | rayrac | |
23/3/2015 18:35 | A 50k buy after the bell should take some sting out of that 82k sell. | luminoso | |
23/3/2015 17:01 | mbayliss, lack of buying pressure. If Ig is correct, any insti's with existing holdings that were privy to the details of the placing, will be in a closed period. buywell, I did previously attempt to discuss approval of various products with you, but you gave no reply. Would you like to say which of the products in which domains you are referring to? | bamboo2 | |
23/3/2015 16:38 | buywell2 - 03 May 2014 - 15:41:10 - 846 of 1223 VOL rising with the drop Chart stands at a decision point 24.5p is a pretty important level What approval has this got ? | buywell2 | |
23/3/2015 16:33 | why the big drop today unless someone knows about the prelim results :-( | mbayliss | |
17/3/2015 10:16 | Buying opp between now and results in May if it dips much below 19p. Those who participated in the placing will still be insiders until then so can't add. So no buying pressure from those wot have seen details of the future prospects (and were impressed to the tune of £20m @ 19p). But no real reason for the price to move much way from 19p until more news is out - it was the fair price for the placing. | igbertsponk | |
17/3/2015 10:10 | Is it just me, or are we under pressure? Don't like it one bit, but got to live with it I'm afraid.😨 | rayrac | |
13/3/2015 11:20 | Quite encouraging info thank you Bamboo! | rayrac | |
11/3/2015 21:01 | Significant shareholders As at 6th March 2015, shareholders holding more than 3% of the share capital of Tissue Regenix Group Plc are: Name of shareholder % of voting rights Invesco Limited 27.82 Woodford Investment Management LLP 14.48 Techtran Group Limited 13.56 Baillie Gifford & Co Ltd 5.38 University of Leeds 4.47 NFU Mutual 4.24 Jupiter 3.69 IP Venture Fund 3.26 John Samuel 3.20 Alan Miller 2.83 Shares not in public hands as at 6th March 2015 – 490,195,914 - 64.53% Shares in issue as at 6th March 2015 - 759,653,093 ordinary shares of 0.5p each | bamboo2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions